These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 11715866)

  • 1. Counting deadly spores.
    Comarow A
    US News World Rep; 2001 Nov; 131(20):22-3. PubMed ID: 11715866
    [No Abstract]   [Full Text] [Related]  

  • 2. Anthrax. Biodefense hampered by inadequate tests.
    Enserink M
    Science; 2001 Nov; 294(5545):1266-7. PubMed ID: 11701907
    [No Abstract]   [Full Text] [Related]  

  • 3. War on terror. Anxious about anthrax.
    Begley S; Isikoff M
    Newsweek; 2001 Oct; 138(17):28-35. PubMed ID: 11682908
    [No Abstract]   [Full Text] [Related]  

  • 4. Unsupported conclusions on the Bacillus anthracis spores.
    Mereish KA
    Appl Environ Microbiol; 2007 Aug; 73(15):5074. PubMed ID: 17660313
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhalational anthrax due to bioterrorism: would current Centers for Disease Control and Prevention guidelines have identified the 11 patients with inhalational anthrax from October through November 2001?
    Mayer TA; Morrison A; Bersoff-Matcha S; Druckenbrod G; Murphy C; Howell J; Hanfling D; Cates R; Pauze D; Earls J
    Clin Infect Dis; 2003 May; 36(10):1275-83. PubMed ID: 12746773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The hunt for the anthrax killers.
    Ripley A
    Time; 2001 Nov; 158(20):34-40, 43. PubMed ID: 11710155
    [No Abstract]   [Full Text] [Related]  

  • 7. The monitoring and detection of Bacillus anthracis in the environment.
    Titball RW; Turnbull PC; Hutson RA
    Soc Appl Bacteriol Symp Ser; 1991; 20():9S-18S. PubMed ID: 1909461
    [No Abstract]   [Full Text] [Related]  

  • 8. Update: Investigation of bioterrorism-related anthrax, 2001.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Nov; 50(45):1008-10. PubMed ID: 11724158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interim guidelines for investigation of and response to Bacillus anthracis exposures.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Nov; 50(44):987-90. PubMed ID: 11724154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of spores of Bacillus anthracis from environment using polymerase chain reaction.
    Alam SI; Agarwal GS; Kamboj DV; Rai GP; Singh L
    Indian J Exp Biol; 2003 Feb; 41(2):177-80. PubMed ID: 15255613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Information on which to base assessments of risk from environments contaminated with anthrax spores.
    Watson A; Keir D
    Epidemiol Infect; 1994 Dec; 113(3):479-90. PubMed ID: 7995358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Learning from the 2001 anthrax attacks: immunological characteristics.
    Hadler JL
    J Infect Dis; 2007 Jan; 195(2):163-4. PubMed ID: 17191158
    [No Abstract]   [Full Text] [Related]  

  • 13. Serious adverse events among participants in the Centers for Disease Control and Prevention's Anthrax Vaccine and Antimicrobial Availability Program for persons at risk for bioterrorism-related inhalational anthrax.
    Tierney BC; Martin SW; Franzke LH; Marano N; Reissman DB; Louchart RD; Goff JA; Rosenstein NE; Sever JL; McNeil MM;
    Clin Infect Dis; 2003 Oct; 37(7):905-11. PubMed ID: 13130401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heat activation/shock temperatures for Bacillus anthracis spores and the issue of spore plate counts versus true numbers of spores.
    Turnbull PC; Frawley DA; Bull RL
    J Microbiol Methods; 2007 Feb; 68(2):353-7. PubMed ID: 17055602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased US prescription trends associated with the CDC Bacillus anthracis antimicrobial postexposure prophylaxis campaign.
    Shaffer D; Armstrong G; Higgins K; Honig P; Coyne P; Boxwell D; Beitz J; Leissa B; Murphy D
    Pharmacoepidemiol Drug Saf; 2003; 12(3):177-82. PubMed ID: 12733470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Taking anthrax's genetic fingerprints.
    Enserink M
    Science; 2001 Nov; 294(5548):1810-2. PubMed ID: 11729278
    [No Abstract]   [Full Text] [Related]  

  • 17. Bacillus anthracis contamination and inhalational anthrax in a mail processing and distribution center.
    Sanderson WT; Stoddard RR; Echt AS; Piacitelli CA; Kim D; Horan J; Davies MM; McCleery RE; Muller P; Schnorr TM; Ward EM; Hales TR
    J Appl Microbiol; 2004; 96(5):1048-56. PubMed ID: 15078521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From the Centers for Disease Control and Prevention. Investigation of bioterrorism-related anthrax, 2001.
    JAMA; 2001 Dec; 286(21):2662-3. PubMed ID: 11763854
    [No Abstract]   [Full Text] [Related]  

  • 19. Bioterrorism watch. They don't call it bioterror for nothing: fear is the foe when anthrax spores are found within hospital walls.
    Evans G
    ED Manag; 2002 Jun; 14(6):suppl 1-3. PubMed ID: 12046239
    [No Abstract]   [Full Text] [Related]  

  • 20. Application of the real-time PCR for the detection of airborne microbial pathogens in reference to the anthrax spores.
    Makino S; Cheun HI
    J Microbiol Methods; 2003 May; 53(2):141-7. PubMed ID: 12654485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.